Take CRISPR Therapeutics (NASDAQ: CRSP) and Intellia Therapeutics (NASDAQ: NTLA), two biotechs specializing in gene editing. Finance, is $83.60; the latter earns a price target of $50.80 from ...

LETI-101 has demonstrated therapeutically relevant reductions of mutant huntingtin (HTT) protein, exceeding 80%, while preserving essential ...

Key Laboratory of Chemical Biology & Traditional Chinese Medicine Research (Ministry of Education), Institute of Interdisciplinary Studies, College of Chemistry and Chemical Engineering, Hunan Normal ...

After hours: February 21 at 7:59:03 p.m. EST ...

通过对 UKBB 数据进行下采样分析发现，随着样本量增加，liability GWAS 中能检测到但 binary GWAS 中未检测到的 SNP 比例逐渐增加，meta GWAS 则在所有样本量下都与 binary GWAS 有较高的重叠率。此外，liability 方法在观察尺度上的 SNP 遗传力（ ）估计值比 binary 方法更高 ...

首先是对参与者进行基因分型和数据处理，从冲绳生物信息库（OBi）和日本生物银行（BBJ）获取参与者信息，对他们的 DNA 进行提取和基因分型，同时进行严格的质量控制，去除不符合要求的样本和单核苷酸多态性（SNP）。接着对数据进行处理和填补。之后 ...